In studies with glioblastoma xenograft tumors and co-culture strategies, it was demonstrated that macrophage migration inhibitory factor (MIF), which is secreted at high levels by CSCs, activated the immunosuppressive phenotype of MDSCs in a CXCR2-dependent manner [135]. Here, MIF is linked to glioblastoma.